Booking Holdings enters the final day of September with its stock down 21% over the past month to $162.34, yet the short-selling community continues to reduce positions and the analyst consensus, though trimming targets, remains firmly bullish.
The most notable shift since last week's note is that the short position has continued its retreat. Short interest now stands at 60.7% of free float, down from 63.1% reported a week ago and off sharply from the August peak above 73% of float. On a one-month basis shorts have shrunk by roughly 15.5%, a meaningful withdrawal even as the stock has continued falling. That divergence, covering pressure building into a weakening tape, is one of the more unusual dynamics in this name right now. Borrow conditions remain completely undemanding. Cost to borrow has dropped nearly 29% over the week to just 0.35%, and availability is effectively unlimited, with shares available to borrow running at more than 9,999% of the short interest figure. The lending pool has zero congestion. Options are equally quiet. The put/call ratio has barely moved, closing at 0.86 against a 20-day average of 0.87. The z-score of negative 0.33 shows options traders are fractionally less defensive than their recent norm. Taken together, positioning looks indifferent rather than aggressive in either direction.
The Street tells a more interesting story. Analyst conviction is still high in absolute terms, with the consensus carrying a mean price target of $238, implying roughly 47% upside from current levels. But the direction of travel in targets is now clearly downward. Truist Securities cut its target this morning from $242 to $216 while keeping its Buy rating, a significant trim that acknowledges the stock's continued underperformance. Morgan Stanley initiated coverage earlier in September at Overweight with a $230 target, a constructive entry but below where several peers had been sitting. BTIG has twice reiterated its $250 target and Rosenblatt initiated at Buy with a $245 target in early September, so there is no shortage of bulls. The factor score for analyst recommendation dispersion ranks at the 93rd percentile, meaning the consensus is unusually tight and positive relative to the broader market. EV/EBITDA has compressed slightly over the past 30 days, now running at around 10.5x, while the trailing PE has pulled back to roughly 13.7x. The bear case centres on valuation leaving little room for disappointment near 16.4x 2027 GAAP EPS if growth momentum slows, while the bull case rests on the company's near-40% EBITDA margins and the roughly $32.7 billion of free cash flow generated over the past five years.
Insider selling has continued but carries limited signal weight. The 90-day net insider position is negative $17.2 million, almost entirely driven by the General Counsel's block of sales in mid-August totalling close to $8.8 million across multiple transactions. All recent trades were executed under pre-arranged 10b5-1 plans, making them routine rather than discretionary signals. The two most recent filings, from the Chief Human Resources Officer in September and a director in early September, were both small and plan-driven. On the institutional side, Capital Research added over 8.2 million shares as of end of August, the largest single-holder change in the register, while the major passive holders (BlackRock at 8.7%, Vanguard at 7.3%) made only marginal adjustments.
Closest peer EXPE fell 5.1% on the week, a steeper drop than BKNG's 1.1% decline, suggesting the softness is not company-specific. ABNB dropped 3.0% and MMYT shed 2.5%, while NCLH bucked the trend with a 4.1% gain. The relative steadiness of BKNG against its most correlated peer this week is a minor reversal of its longer-term underperformance trend.
The next earnings date is October 29. With Q2 having delivered a 7.4% next-day jump and an 10.5% five-day gain, and Q1 producing a 4.2% next-day decline, the print history is genuinely mixed. The key question going into October 29 is whether the Street's unusually tight bullish consensus, combined with a diminishing short base, can hold against a stock that has shed a fifth of its value in a month with no obvious single catalyst.
See the live data behind this article on ORTEX.
Open BKNG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
